Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness.

Mol Ther · 2023 · PMC10492026 · PMID 37481704

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

nearly statistically significantp = 0.055so close (0.05 < p ≤ 0.1)

74.3 ± 2.97 dB SPL, respectively; p < 0.01, two-way ANOVA with Holm-Šidák correction) and a nearly statistically significant difference at 16 kHz (65.0 ± 2.24 dB SPL vs. 75.7 ± 0.71 dB SPL, respectively; p = 0.055, two-way ANOVA with Holm-Šidák correction; Figure 6 A).

also in 78 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.